Functional and epigenetic consequences of maternal folate deficiency, supplementation and fetal growth restriction
Functional and epigenetic consequences of maternal folate deficiency, supplementation and fetal growth restriction
批准号:
nhmrc : 453640
负责人:
Dr Marie Dziadek
金额:
$36.35万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Growing slowly before birth or being born early and premature are very common. Both conditions greatly increase the risk of illness or death around birth and of the infant developing major conditions such as diabetes and cardiovascular disease in later life. Despite their importance, we understand little of what causes fetal growth failure or prematurity or why they influence an individual's health throughout life. Recent findings suggest that low levels of folate in the mother, due to either dietary or genetic factors, may be involved in their origins and their long-term outcomes. Folate is a nutrient required regularly in small amounts for growth and maintenance of health. Folate supplementation in women is currently recommended before and in early pregnancy, but may have a role throughout the whole of pregnancy in promoting growth and health of the infant. Using experimental models, this project will determine if too little or too much maternal folate modifies the genetic code of the infant (called epigenetic changes), which leads to later metabolic disease and high blood pressure. These epigenetic changes are mild and subtle chemical modifications of DNA that persist in the cells of the infant altering their function. The efficacy of maternal folate supplementation in improving these outcomes for the small baby will also be tested in the models. Finally, the effect of folate status in the normal and small human infant on the epigenetic state of their placenta, cord blood white blood cells and mucous cells of the mouth will be tested. These outcomes will enable the design and testing of interventions with folate and related nutrients in the mother to improve the health of their babies before birth and subsequently throughout their lives. Because these pregnancy complications of being born small or early are common and account for much of the diabetes that occurs in later life, the health benefits from development of effective interventions may be large.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A model of muscle development and tumorigenesis: the role of Stim1.
-
批准号:nhmrc : 990476
-
项目类别:NHMRC Project Grants
-
资助金额:$12.99万
-
财政年份:1999
-
负责人:Dr Marie Dziadek
-
依托单位:
Function of collagen VI in tissue development
-
批准号:nhmrc : 980738
-
项目类别:NHMRC Project Grants
-
资助金额:$12.3万
-
财政年份:1998
-
负责人:Dr Marie Dziadek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
-
批准号:82371092
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:柯碧莲
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
MCM2、POLE3调控亲代组蛋白传递的分子机制和生物学功能
-
批准号:32070610
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:甘海云
-
依托单位:
转录因子剂量效应调控体细胞重编程的表观遗传机制研究
-
批准号:31970681
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘晶
-
依托单位:
组蛋白分子伴侣FACT调控异染色质转录沉默的作用机制研究
-
批准号:31900433
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:杨佳怡
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
-
批准号:30872933
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:张权庚
-
依托单位:
高等植物远缘杂交诱导的表观遗传变异(epigenetic variation)现象及其在物种进化和新种形成中的作用
-
批准号:30430060
-
项目类别:重点项目
-
资助金额:140.0万元
-
批准年份:2004
-
负责人:刘宝
-
依托单位: